New Therapeutic Modalities

Browse venture capital firms focused on New Therapeutic Modalities.

Explore VC firms that invest in New Therapeutic Modalities. Filter by country and stage to refine results.

1 of 200 firms
Filters:
Boehringer Ingelheim Venture Fund favicon
Boehringer Ingelheim Venture Fund
Germany, United States, China

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation. It invests in pioneering science with the potential for significant patient benefit, focusing on areas like immunology, regenerative medicine, and digital health. The fund provides financial support and strategic guidance to portfolio companies.

Founded 2010
Investment Stages
Seed
Series A
Series B
Markets
Immunomodulation
Immuno-Oncology
Tissue Regeneration
New Therapeutic Modalities
Gene Therapy
Cell-based therapeutics
Microbiome
Antiinfectives
Patients Care Management
Digital Health